MDVN’s CC today on Talazoparib had some useful information, but the information density was extremely low. It took 102 minutes to say what could’ve been said in about 12 minutes.
The purpose of the call was, of course, to boost the value ascribed to Talazoparib in buyout offers MDVN is entertaining (#msg-123698172).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”